Patents by Inventor Christopher S. Mudd
Christopher S. Mudd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20190308007Abstract: Described herein are injection devices capable of automatically injecting substances into the soft tissue of a patient. The devices can inject low to high viscosity materials at predetermined, user selected injection rates, allowing the operator more control than a traditional syringe. The devices can allow mixing of more than one substance and/or reconstitution of a solid substance for injection. The injection devices described herein can allow the operator to easily inject one or more low to high viscosity liquid or gel soft-tissue augmentation fillers, one or more drugs, one or more other biocompatible materials, or combinations thereof.Type: ApplicationFiled: April 19, 2019Publication date: October 10, 2019Inventors: Christopher S. MUDD, Ahmet TEZEL
-
Publication number: 20190209789Abstract: A needle assembly for an injection device is provided to facilitate delivery of a dermal filler. The assembly includes a cannula and a hub. The hub can be coupled to a syringe. The hub includes an inner bore that has a proximal retention section, a stepped section, and a cannula retention section. The stepped section, the proximal retention section, and the cannula retention section are configured to reduce the dead space within the inner bore for preventing detachment of the hub from the syringe during an injection procedure.Type: ApplicationFiled: March 19, 2019Publication date: July 11, 2019Inventors: Ahmet TEZEL, Kevin McNERNEY, Christopher S. MUDD, Blake R. STORIE, Bastien MANDAROUX
-
Patent number: 10279162Abstract: Described herein are injection devices capable of automatically injecting substances into the soft tissue of a patient. The devices can inject low to high viscosity materials at predetermined, user selected injection rates, allowing the operator more control than a traditional syringe. The devices can allow mixing of more than one substance and/or reconstitution of a solid substance for injection. The injection devices described herein can allow the operator to easily inject one or more low to high viscosity liquid or gel soft-tissue augmentation fillers, one or more drugs, one or more other biocompatible materials, or combinations thereof.Type: GrantFiled: December 1, 2016Date of Patent: May 7, 2019Assignee: ALLERGAN, INC.Inventors: Christopher S. Mudd, Ahmet Tezel
-
Patent number: 10232129Abstract: An injection device includes a syringe having a body with a piston disposed therein with an open end along with a viscous fluid disposed in the body for injection by the piston. A needle assembly is provided which includes a cannula having a luer connection engageable with the syringe distal end with the luer connector including a hub. Mating engagement is provided by way of internal threads at the syringe distal end and external threads of a hub with a pitch sufficient to prevent detachment of the hub from the syringe distal end during ejection of the viscous fluid. In addition, a stepped cavity, disposed in the hub, further prevents detachment of the hub from the syringe distal end during ejection of the viscous fluid.Type: GrantFiled: December 2, 2009Date of Patent: March 19, 2019Assignee: Allergan, Inc.Inventors: Ahmet Tezel, Kevin McNerney, Christopher S. Mudd, Blake R. Storie, Bastien Mandaroux
-
Publication number: 20190008669Abstract: An intragastric implant for obesity treatment is disclosed. The device delays digestion by providing a duodenal sleeve, and may also slows gastric emptying by limiting flow through the pyloric sphincter. The implant includes an elongated axially-compressible duodenal sleeve having a non-tissue-piercing anchor on a proximal end sized to lodge within the duodenal bulb. The anchor may have oppositely-directed anchoring flanges to resists migration in both directions. The sleeve may also have barbed ribs to resist proximal movement back up into the stomach. A method of implant includes collapsing/compressing the device and transorally advancing it through the esophagus to be deployed within the duodenum. A dissolvable jacket may constrain the implant for delivery and naturally dissolve upon implant. Removal of the implant may occur in the reverse.Type: ApplicationFiled: September 10, 2018Publication date: January 10, 2019Applicant: Apollo Endosurgery, Inc.Inventors: Mitchell H. Babkes, Zachary P. Dominguez, Christopher S. Mudd
-
Patent number: 10070980Abstract: An intragastric implant for obesity treatment is disclosed. The device delays digestion by providing a duodenal sleeve, and may also slows gastric emptying by limiting flow through the pyloric sphincter. The implant includes an elongated axially-compressible duodenal sleeve having a non-tissue-piercing anchor on a proximal end sized to lodge within the duodenal bulb. The anchor may have oppositely-directed anchoring flanges to resists migration in both directions. The sleeve may also have barbed ribs to resist proximal movement back up into the stomach. A method of implant includes collapsing/compressing the device and transorally advancing it through the esophagus to be deployed within the duodenum. A dissolvable jacket may constrain the implant for delivery and naturally dissolve upon implant. Removal of the implant may occur in the reverse.Type: GrantFiled: June 18, 2013Date of Patent: September 11, 2018Assignee: APOLLO ENDOSURGERY US, INC.Inventors: Mitchell H. Babkes, Zachary P. Dominguez, Christopher S. Mudd
-
Patent number: 9795498Abstract: A transorally implanted intragastric balloon or treating obesity and for weight control including a variable size balloon with one or interconnected regions acting to exert a pressure on the stomach, to provide a stomach volume occupying effect, and/or to anchor the balloon within the stomach.Type: GrantFiled: October 3, 2013Date of Patent: October 24, 2017Assignee: APOLLO ENDOSURGERY US, INC.Inventors: Justin J. Schwab, Zachary P. Dominguez, Joseph S. Raven, Mitchell H. Babkes, Christopher S. Mudd, Tiago Bertolote
-
Patent number: 9750884Abstract: A syringe is disclosed.Type: GrantFiled: February 9, 2015Date of Patent: September 5, 2017Assignee: Allergan, Inc.Inventors: Dimitrios Stroumpoulis, Christopher S. Mudd
-
Patent number: 9681974Abstract: Transoral obesity treatment devices and related methods for operation thereof are described which occupy space within a stomach and/or stimulate the stomach wall. The transoral obesity treatment devices and related methods are intended to assist a patient in maintaining a healthy body weight. Features of the devices include insertion transorally and without invasive surgery, without associated patient risks of invasive surgery, and without substantial patient discomfort. The life span of these devices may be material-dependent upon long-term survivability within an acidic stomach, but is intended to last one year or longer. The devices have the capacity to vary in size and are desirably self-actuating in that they change shape and/or volume using internal motors or actuators. The changing character of the devices helps prevent the person's stomach from compensating for the implant, such as sometimes happens with static intragastric devices.Type: GrantFiled: October 21, 2014Date of Patent: June 20, 2017Assignee: Apollo Endosurgery US, Inc.Inventors: Zachary Dominguez, Mitchell H. Babkes, Justin Schwab, Christopher S. Mudd, Jason Metzner
-
Publication number: 20170080154Abstract: Described herein are injection devices capable of automatically injecting substances into the soft tissue of a patient. The devices can inject low to high viscosity materials at predetermined, user selected injection rates, allowing the operator more control than a traditional syringe. The devices can allow mixing of more than one substance and/or reconstitution of a solid substance for injection. The injection devices described herein can allow the operator to easily inject one or more low to high viscosity liquid or gel soft-tissue augmentation fillers, one or more drugs, one or more other biocompatible materials, or combinations thereof.Type: ApplicationFiled: December 1, 2016Publication date: March 23, 2017Inventors: Christopher S. Mudd, Ahmet Tezel
-
Patent number: 9498365Abstract: An intragastric obesity treatment implant promotes a feeling of satiety in the patient by contacting the insides of the stomach wall, reducing the space in the stomach, or otherwise reducing the amount of food consumed. One intragastric obesity treatment implant two inflatable balloons coupled via a flow restrictor through which fluid may flow in response to peristaltic motions of a patient's stomach. Additionally, one implant comprises a pumping chamber coupled to a reservoir, where the pumping chamber moves stomach fluids into the reservoir in response to peristaltic motions of the patient's stomach.Type: GrantFiled: October 17, 2011Date of Patent: November 22, 2016Assignee: Apollo Endosurgery, Inc.Inventors: Mitchell H. Babkes, Zachary Dominguez, Christopher S. Mudd, Craig Olroyd, Jonathan Daugusta
-
Publication number: 20160331568Abstract: A transorally implanted intragastric balloon or treating obesity and for weight control including a variable size balloon with one or interconnected regions acting to exert a pressure on the stomach, to provide a stomach volume occupying effect, and/or to anchor the balloon within the stomach.Type: ApplicationFiled: October 3, 2013Publication date: November 17, 2016Applicant: APOLLO ENDOSURGERY, INC.Inventors: Justin J. Schwab, Zachary P. Dominguez, Joseph S. Raven, Mitchell H. Babkes, Christopher S. Mudd, Tiago Bertolote
-
Patent number: 9468720Abstract: In one embodiment, the handheld injection device includes a first housing having a first axis and a second housing having a second axis. In one embodiment, the second housing is configured to support a needle. In one embodiment, the first axis and a second axis form an adjustable angle between about 180 degrees and about 90 degrees.Type: GrantFiled: November 12, 2013Date of Patent: October 18, 2016Assignee: Allergan, Inc.Inventors: Christopher S. Mudd, Mitchell H. Babkes, Zachary Dominguez, Michael J. Prichard, Martha E. Llewellyn, Shaohui Qiu, Lee F. Powers, Brett R. Johnson
-
Publication number: 20160114101Abstract: An injection device enables a user to control the dilution ratio of mixed injectable fluid. In one embodiment, the injection device includes a drive unit configured to apply extrusion forces to fluids. In one embodiment, the injection device produces the mixed injectable fluid based on a selected dilution ratio. In one embodiment, the injection device produces the mixed injectable fluid based on selected injection rates.Type: ApplicationFiled: January 7, 2016Publication date: April 28, 2016Inventors: Christopher S. Mudd, Mitchell H. Babkes, Zachary P. Dominguez, Michael J. Prichard, Martha E. Llewellyn, Shaohui Qiu, Lee F. Powers, Brett R. Johnson
-
Patent number: 9220843Abstract: A medical syringe with an extendible plunger rod is provided which facilitates injection of a large volume of material, for example, a dermal filler. The rod may include an outer plunger rod, an inner plunger rod, a compression spring configured to exert force tending to push the inner plunger rod in a direction distal to the outer plunger rod, and a locking mechanism. The locking mechanism prevents movement of the inner plunger rod relative to the outer plunger rod while both the inner and outer plunger rods are depressed, until the outer plunger rod has been depressed a first predetermined distance.Type: GrantFiled: August 16, 2013Date of Patent: December 29, 2015Assignee: Allergan, Inc.Inventor: Christopher S. Mudd
-
Publication number: 20150272761Abstract: A transorally implanted intragastric balloon or treating obesity and for weight control including a variable size balloon with one or interconnected regions acting to exert a pressure on the stomach, to provide a stomach volume occupying effect, and/or to anchor the balloon within the stomach.Type: ApplicationFiled: October 3, 2013Publication date: October 1, 2015Applicant: APOLLO ENDOSURGERY, INC.Inventors: Justin J. Schwab, Zachary P. Dominguez, Joseph S. Raven, Mitchell H. Babkes, Christopher S. Mudd, Tiago Bertolote
-
Publication number: 20150151052Abstract: A syringe is disclosed.Type: ApplicationFiled: February 9, 2015Publication date: June 4, 2015Inventors: Dimitrios Stroumpoulis, Christopher S. Mudd
-
Patent number: 9023063Abstract: A system for attaching an access port to bodily tissue includes an access port assembly and including an access port having a generally central axis. The access port assembly further includes an attachment mechanism structured to enable the access port to be attached, for example, to an abdominal muscle of a patient. The system includes a safety cap which lies substantially flush against the anchor base to provide no space for movement of the anchors. The safety cap prevents the anchors from deploying prematurely.Type: GrantFiled: March 30, 2010Date of Patent: May 5, 2015Assignee: Apollo Endosurgery, Inc.Inventors: Ethan Franklin, Craig Olroyd, Christopher S. Mudd
-
Publication number: 20150094753Abstract: Transoral obesity treatment devices and related methods for operation thereof are described which occupy space within a stomach and/or stimulate the stomach wall. The transoral obesity treatment devices and related methods are intended to assist a patient in maintaining a healthy body weight. Features of the devices include insertion transorally and without invasive surgery, without associated patient risks of invasive surgery, and without substantial patient discomfort. The life span of these devices may be material-dependent upon long-term survivability within an acidic stomach, but is intended to last one year or longer. The devices have the capacity to vary in size and are desirably self-actuating in that they change shape and/or volume using internal motors or actuators. The changing character of the devices helps prevent the person's stomach from compensating for the implant, such as sometimes happens with static intragastric devices.Type: ApplicationFiled: October 21, 2014Publication date: April 2, 2015Applicant: APOLLO ENDOSURGERY, INC.Inventors: Zachary Dominguez, Mitchell H. Babkes, Justin Schwab, Christopher S. Mudd, Jason Metzner
-
Patent number: 8961474Abstract: A syringe is disclosed.Type: GrantFiled: December 15, 2010Date of Patent: February 24, 2015Assignee: Allergan, Inc.Inventors: Dimitrios Stroumpoulis, Christopher S. Mudd